Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-05

Clinical Trial Update: Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating levamisole and isoprinosine for immune-prophylaxis against COVID-19 in Egyptian healthcare workers; status currently UNKNOW…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoprinosine (inosine pranobex)
  • Levamisole (levamisole)

Snippet

Sponsor: Ain Shams University | Conditions: Coronavirus Disease (COVID-19) | Phase 3 | Status: UNKNOWN